Home
Proposals for the future

General Scope

  • Strengthening transversal programs that cross the three fields of research (basic, translational and clinical-epidemiological).
  • Establishing mechanisms to potentiate the synergy between the groups from the three research areas (Basic, Applied and Translational-Clinical and Experimental).
  • Establish a coherent and consistent policy for recruitment of new researchers.
  • Establish a coherent strategy for sustained fund raising
  • Potentiate scientific and technical services that enhance the three areas of search (Basic, Applied and Translational-Clinical and Experimental).
  • Create a specific program to generate interaction between the IRBLleida groups and other research groups from the Parque Científico Tecnológico Agroalimentario de Lleida.
  • Potentiate interaction with the biomedical and biotechnological industry.
  • Potentiate the relationship between the IRBLleida and the civil society.

Field of basic and translational biomedical search

  • Enabling new spaces for basic and translational research.
  • Enable research areas in mixed-use (teaching-reasearch) buildings.
  • In this building the research labs will be located mostly on the third and fourth floors, with an animal house that ocupe a total of 600 m2. Here are the plans for these two floors.
  • Spaces at the new research building. This building will be built in two phases of 4,000 m2 each, within the campus of HUAV. The first phase of this building was financed through a grant from the National R+D+I program for research projects located in science and technology parks (Round of 11 April 2006, BOE of 28 April 2006).
  • The complete distribution of spaces is as follows.
COMMON SERVICES 2550 m2
LABORATORIES 3024 m2
ADMINISTRATION 740 m2
TOTAL USABLE AREA 6314 m2
TOTAL AREA TO BUILD 8000 m2



  • Construction and preparation of new areas of research in synergy with the Scientific and Technological Park of Lleida.
  • Integration of research groups in National and European networks.
  • Incorporation of new researchers to complement current research groups and increase the competitiveness of the IRBLleida.
  • Favour the creation of new research groups.
  • Develop a plan for investment in new infrastructure.

Scope of clinical and epidemiological research and clinical trials

  • Enhancing the performance of clinical drug trials and post-approvalstudies (EPA).
  • To promote research in health care EVALUATION.
  • Creation of a specific service to support management of projects, research funds and research personel.
  • Creation of a specific service of biostatistics and methodological support.
  • Professionalization of CEIC and HUAV.
  • Better training in the design and development of pharmacoepidemiology studies and clinical trials.